Comparison of drug concentrations between whole blood and oral fluid

Drug Testing and Analysis

Volumn 6, Issue 5, 2014, Pages 461-471

  Langel, Kaarina ^a   Gjerde, Hallvard ^b   Favretto, Donata ^c   Lillsunde, Pirjo ^a   Øiestad, Elisabeth Leere ^b   Ferrara, Santo Davide ^c   Verstraete, Alain G ^d  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^c UNIVERSITY OF PADUA MEDICAL SCHOOL   (Italy)

^d GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Driving under the influence; Drugs of abuse; DRUID project; Oral fluid to whole blood ratio

Indexed keywords

BLOOD; DRUG PRODUCTS; GAS CHROMATOGRAPHY; MASS SPECTROMETRY; METABOLITES;

BLOOD CONCENTRATIONS; CORRELATION OF CONCENTRATIONS; DRIVING UNDER THE INFLUENCE; DRUG CONCENTRATION; DRUG OF ABUSE; DRUID PROJECT; LINEAR CORRELATION; ORAL FLUID TO WHOLE BLOOD RATIO; ORAL FLUIDS; WHOLE BLOOD;

LIQUID CHROMATOGRAPHY;

ALPRAZOLAM; AMITRIPTYLINE; AMPHETAMINE; AMPHETAMINE DERIVATIVE; BENZODIAZEPINE DERIVATIVE; BENZOYLECGONINE; BROMAZEPAM; CANNABIS; CLONAZEPAM; COCAINE; CODEINE; DIAZEPAM; DRUG; LORAZEPAM; METHADONE; METHAMPHETAMINE; MIRTAZAPINE; MORPHINE; NORDAZEPAM; OPIATE; OXAZEPAM; PSYCHOTROPIC AGENT; TETRAHYDROCANNABINOL; TRAMADOL; TRAZODONE; ZOLPIDEM; ZOPICLONE; STREET DRUG;

ARTICLE; BELGIUM; BLOOD; BLOOD SAMPLING; CONTROLLED STUDY; DRUG SCREENING; DRUG USE; FINLAND; HUMAN; ITALY; LIQUID; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; METABOLITE; NORMAL HUMAN; NORWAY; ORAL FLUID; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; SALIVA; BLOOD ANALYSIS; CHEMISTRY; COMPARATIVE STUDY; MASS FRAGMENTOGRAPHY; PROCEDURES; SUBSTANCE ABUSE;

BLOOD CHEMICAL ANALYSIS; CHROMATOGRAPHY, LIQUID; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; MASS SPECTROMETRY; PSYCHOTROPIC DRUGS; SALIVA; STREET DRUGS; SUBSTANCE ABUSE DETECTION;

EID: 84899953147     PISSN: 19427603     EISSN: 19427611     Source Type: Journal    
DOI: 10.1002/dta.1532     Document Type: Article

References (56)

1. O.H. Drummer, D. Gerostamoulos, M. Chu, P. Swann, M. Boorman, I. Cairns . Drugs in oral fluid in randomly selected drivers. Forensic Sci. Int. 2007, 170, 105.
2. T. Blencowe, A. Pehrsson, P. Lillsunde . Analytical Evaluation of Oral Fluid Screening Devices and Preceding Selection Procedures. DRUID Deliverable D3.2.2, National Institute for Health and Welfare, Helsinki, 2010.
3. A.G. Verstraete . More reliable on-site detection of cannabis in oral fluid. Clin. Chem. 2012, 58, 1389.
4. E.J. Cone . Saliva testing for drugs of abuse. Ann. NY Acad. Sci. 1993, 694, 91.
5. N. De Giovanni, N. Fucci . The state of the art on the use of oral fluid as alternative specimen in forensic toxicology. Curr. Pharm. Anal. 2008, 4, 258.
6. W.M. Bosker, M.A. Huestis . Oral fluid testing for drugs of abuse. Clin. Chem. 2009, 55, 1910.
7. C.D.R. de Oliveira, M. Roehsig, R.M. de Almeida, W.L. Rocha, M. Yonamine . Recent advances in chromatographic methods to detect drugs of abuse in alternative biological matrices. Curr. Pharm. Anal. 2007, 3, 95.
8. O.H. Drummer . Drug testing in oral fluid. Clin. Biochem. Rev. 2006, 27, 147.
9. D.A. Kidwell, J.C. Holland, S. Athanaselis . Testing for drugs of abuse in saliva and sweat. J. Chromatogr. B 1998, 713, 111.
10. K. Pil, A.G. Verstraete . Current developments in drug testing in oral fluid. Ther. Drug Monit. 2008, 30, 196.
11. N. Samyn, A.G. Verstraete, C. van Haeren, P. Kintz . Analysis of drugs of abuse in saliva. Forensic Sci. Rev. 1999, 11, 1.
12. S. Townsend, L. Fanning, R. O'Kennedy . Salivary analysis of drugs - Potential and difficulties. Anal. Lett. 2008, 41, 925.
13. A.G. Verstraete . Oral fluid testing for driving under the influence of drugs: History, recent progress and remaining challenges. Forensic Sci. Int. 2005, 150, 143.
14. A.G. Verstraete . Detection times of drugs of abuse in blood, urine, and oral fluid. Ther. Drug Monit. 2004, 26, 200.
15. R. Haeckel . Factors influencing the saliva plasma ratio of drugs. Ann. NY Acad. Sci. 1993, 694, 128.
16. D.J. Crouch . Oral fluid collection: The neglected variable in oral fluid testing. Forensic Sci. Int. 2005, 150, 165.
17. E.J. Cone, J. Oyler, W.D. Darwin . Cocaine disposition in saliva following intravenous, intranasal, and smoked administration. J. Anal. Toxicol. 1997, 21, 465.
18. M.A. Huestis, E.J. Cone . Relationship of Delta(9)-tetrahydrocannabinol concentrations in oral fluid and plasma after controlled administration of smoked cannabis. J. Anal. Toxicol. 2004, 28, 394.
19. K.B. Scheidweiler, E.A.K. Spargo, T.L. Kelly, E.J. Cone, A.J. Barnes, M.A. Huestis . Pharmacokinetics of cocaine and metabolites in human oral fluid and correlation with plasma concentrations after controlled administration. Ther. Drug Monit. 2010, 32, 628.
20. R.J.F. Schepers, J.M. Oyler, R.E. Joseph, E.J. Cone, E.T. Moolchan, M.A. Huestis . Methamphetamine and amphetamine pharmacokinetics in oral fluid and plasma after controlled oral methamphetamine administration to human volunteers. Clin. Chem. 2003, 49, 121.
21. S.M.R. Wille, E. Raes, P. Lillsunde, T. Gunnar, M. Laloup, N. Samyn, et al. Relationship between oral fluid and blood concentrations of drugs of abuse in drivers suspected of driving under the influence of drugs. Ther. Drug Monit. 2009, 31, 511.
22. S.W. Toennes, G.F. Kauert, S. Steinmeyer, M.R. Moeller . Driving under the influence of drugs - evaluation of analytical data of drugs in oral fluid, serum and urine, and correlation with impairment symptoms. Forensic Sci. Int. 2005, 152, 149.
23. H. Gjerde, J. Mordal, A.S. Christophersen, J.G. Bramness, J. Mørland . Comparison of drug concentrations in blood and oral fluid collected with the intercept (R) sampling device. J. Anal. Toxicol. 2010, 34, 204.
24. H. Schulze, M. Schumacher, R. Urmeew, K. Auerbach, J. Alvarez, I.M. Bernhoft, et al. Driving Under the Influence of Drugs, Alcohol and Medicines in Europe - Findings from the DRUID Project, European Monitoring Centre for Drugs and Drug Addiction, Lisbon, 2012.
25. V. Vindenes, H.M.E. Lund, W. Andresen, H. Gjerde, S.E. Ikdahl, A.S. Christophersen, et al. Detection of drugs of abuse in simultaneously collected oral fluid, urine and blood from Norwegian drug drivers. Forensic Sci. Int. 2012, 219, 165.
26. K. Langel, C. Engblom, A. Pehrsson, T. Gunnar, K. Ariniemi, P. Lillsunde . Drug testing in oral fluid - Evaluation of sample collection devices. J. Anal. Toxicol. 2008, 32, 393.
27. A. Pehrsson, T. Blencowe, K. Vimpari, K. Langel, C. Engblom, P. Lillsunde . An evaluation of on-site oral fluid drug screening devices Drugwipe (R) 5(+) and rapid STAT (R) using oral fluid for confirmation analysis. J. Anal. Toxicol. 2011, 35, 211.
28. A.S. Goessaert, K. Pil, J. Veramme, A.G. Verstraete . Analytical evaluation of a rapid on-site oral fluid drug test. Anal. Bioanal. Chem. 2010, 396, 2461.
29. K. Langel, T. Gunnar, K. Ariniemi, O. Rajamäki, P. Lillsunde . A validated method for the detection of 50 drugs of abuse and medicinal drugs in oral fluid by gas chromatography-mass spectrometry. J. Chromatogr. B 2010, 879, 859.
30. A. Pehrsson, T. Gunnar, C. Engblom, H. Seppä, A. Jama, P. Lillsunde . Roadside oral fluid testing: Comparison of the results of Drugwipe 5 and Drugwipe Benzodiazepines on-site tests with laboratory confirmation results of oral fluid and whole blood. Forensic Sci. Int. 2008, 175, 140.
31. T. Gunnar, T. Eskola, P. Lillsunde . Fast gas chromatography/mass spectrometric assay for the validated quantitative determination of methadone and the primary metabolite EDDP in whole blood. Rapid Commun. Mass Spectrom. 2006, 20, 673.
32. T. Van der Linden, S.-A. Legrand, P. Silverans, A.G. Verstraete . DUID: Oral fluid and blood confirmation compared in Belgium. J. Anal. Toxicol. 2012, 36, 418.
33. S.D. Ferrara, D. Favretto, M. Montisci, S. Vogliardi, G. Stocchero, G. Viel, et al. in Prevalence of Alcohol and Other Psychoactive Substances in Drivers in General Traffic. Part II: Country Reports. DRUID Deliverable D2.2.3, (Eds: S. Houwing, M. Hagenzieker, R. Mathijssen, I.M. Bernhoft, T. Hels, K. Janstrup, T. Van der Linden, S.-A. Legrand, A.G. Verstraete), SWOV Institute for Road Safety Research, Leidschendam, 2011.
34. S.D. Ferrara, D. Favretto, M. Montisci, S. Vogliardi, G. Stocchero, G. Viel, et al. in Prevalence of Alcohol and Other Psychoactive Substances in Drivers in Injured and Killed Drivers. DRUID Deliverable D2.2.5, (Eds: C. Isalberti, T. Van der Linden, S.-A. Legrand, A.G. Verstraete, I.M. Bernhoft, T. Hels, M.N. Olesen, S. Houwing, M. Houtenbos, R. Mathijssen), University of Ghent, Ghent, 2011, pp. 251-271.
35. H.M.E. Lund, E.L. Øiestad, H. Gjerde, A.S. Christophersen . Drugs of abuse in oral fluid collected by two different sample kits - Stability testing and validation using ultra performance tandem mass spectrometry analysis. J. Chromatogr. B 2011, 879, 3367.
36. S. Houwing, M. Hagenzieker, R. Mathijssen, I.M. Bernhoft, T. Hels, K. Janstrup, et al. Prevalence of Alcohol and Other Psychoactive Substances in Drivers in General Traffic. DRUID Report D2.2.3, SWOV Institute for Road Safety Research, Leidschendam, 2011.
37. K. Pil, F.M. Esposito, A.G. Verstraete . External quality assessment of multi-analyte chromatographic methods in oral fluid. Clin. Chim. Acta 2010, 411, 1041.
38. K. Pil, E. Raes, A.G. Verstraete . The toxicological challenges in the European research project DRUID. Forensic Sci. Int. Supplement Series 2009, 1, 29.
39. A.W. Jones, H. Larsson . Distribution of diazepam and nordiazepam between plasma and whole blood and the influence of hematocrit. Ther. Drug Monit. 2004, 26, 380.
40. S.B. Matin, S.H. Wan, J.H. Karam . Pharmacokinetics of tolbutamide: Prediction by concentration in saliva. Clin. Pharmacol. Ther. 1974, 16, 1052.
41. J.C. Mucklow . Review: The use of saliva in therapeutic drug monitoring. Ther. Drug Monit. 1982, 4, 229.
42. A.G. Verstraete, E. Raes . ROSITA-2 Project, Final Report, Academia Press, Ghent, 2006.
43. C. Engblom, T. Gunnar, A. Rantanen, P. Lillsunde . Driving under the influence of drugs-amphetamine concentrations in oral fluid and whole blood samples. J. Anal. Toxicol. 2007, 31, 276.
44. H. Gjerde, E.L. Øiestad, A.M.L. Øiestad, M. Langødegård, I. Gustavsen, K. Hjelmeland, et al. Comparison of Zopiclone concentrations in oral fluid sampled with intercept (R) oral specimen collection device and statsure saliva sampler (TM) and concentrations in blood. J. Anal. Toxicol. 2010, 34, 590.
45. R.S. Niedbala, K.W. Kardos, D.F. Fritch, S. Kardos, T. Fries, J. Waga . Detection of marijuana use by oral fluid and urine analysis following single-dose administration of smoked and oral marijuana. J. Anal. Toxicol. 2001, 25, 289.
46. D. Lee, G. Milman, A.J. Barnes, R.S. Goodwin, J. Hirvonen, M.A. Huestis . Oral fluid cannabinoids in chronic, daily cannabis smokers during sustained, monitored abstinence. Clin. Chem. 2011, 57, 1127.
47. H. Gjerde, P.T. Normann, A.S. Christophersen . The prevalence of alcohol and drugs in sampled oral fluid is related to sample volume. J. Anal. Toxicol. 2010, 34, 416.
48. A. Moffat, M. Osselton, B. Widdop . Clarke's Analysis of Drugs and Poisons, 3rd Edn, Pharmaceutical Press, London, 2004.
49. M.A. Huestis, E.J. Cone . Methamphetamine disposition in oral fluid, plasma, and urine. Ann. NY Acad. Sci. 2007, 1098, 104.
50. G. Caille, P. Dusouich, J. Spenard, Y. Lacasse, M. Vezina . Pharmacokinetic and clinical-parameters of zopiclone and trimipramine when administered simultaneously to volunteers. Biopharm. Drug Dispos. 1984, 5, 117.
51. C. Foulon, M.C. Menet, N. Manuel, C. Pham-Huy, H. Galons, J.-R. Claude, et al. Rapid analysis of benzoylecgonine, cocaine, and cocaethylene in urine, serum, and saliva by isocratic high-performance liquid chromatography with diode-array detection. Chromatographia 1999, 50, 721.
52. R. Baselt . Disposition of Toxic Drugs and Chemicals in Man, 7th Edn, Biomedical Publications, Foster City, 2004.
53. J. Säilä . Comparing the Concentrations of Drugs and Medicines in Whole Blood, Plasma and Saliva Samples of Drivers Suspected of Driving Under the Influence, Metropolia University of Applied Sciences, Helsinki, 2009.
54. G. Skopp . Preanalytic aspects in postmortem toxicology. Forensic Sci. Int. 2004, 142, 75.
55. F. Couper, B. Logan . Drugs and Human Performance Fact Sheets, National Highway Traffic Safety Administration, Washington, 2004.
56. H. Schull . Normal disposition of oxazepam in acute viral hepatitis and cirrhosis. Ann. Intern. Med. 1976, 84, 420.